These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18062332)

  • 1. [Pharmacotherapy of a geriatric patient with Parkinson's disease].
    Klemmer JM; Schmitz S; Roth S; Simons S; Reineking N; Eisert A; Lang B; Jaehde U
    Med Monatsschr Pharm; 2007 Nov; 30(11):411-4. PubMed ID: 18062332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
    Anglès A; Bagheri H; Saivin S; Montastruc JL
    Therapie; 2002; 57(4):408-10. PubMed ID: 12422563
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug interactions in the treatment of Parkinson's disease.
    Jost WH; Brück C
    J Neurol; 2002 Oct; 249 Suppl 3():III/24-9. PubMed ID: 12522568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide.
    Chung EJ; Yoon WT; Kim JY; Lee WY
    Mov Disord; 2006 Apr; 21(4):586-7. PubMed ID: 16482572
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nursing process: nursing of patients with Parkinson's disease. Nursing before and after withdrawal for the purpose of medication control of patients with Parkinson's disease].
    Kanagawa M; Osaga W; Ishii T; Saika M; Ishii T
    Kurinikaru Sutadi; 1985 Aug; 6(8):933-9. PubMed ID: 3850295
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to antiparkinson medication in a multicenter European study.
    Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
    Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early, nondisabling Parkinson's disease: weighing the options for initial therapy.
    Silver DE
    Neurol Clin; 2008 Aug; 26(3 Suppl):S1-13, v. PubMed ID: 18774439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electromyography parameters of muscular fatigue and recovery in patients with Parkinson's disease before and on medication].
    Antonen EG; Meĭgal AIu; Lupandin IuV
    Fiziol Cheloveka; 2005; 31(4):81-7. PubMed ID: 16122039
    [No Abstract]   [Full Text] [Related]  

  • 11. Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease.
    Nomoto M; Nishikawa N; Nagai M; Yabe H; Nakatsuka A; Moritoyo H; Moritoyo T; Kubo M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S21-4. PubMed ID: 19131037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dangers in drug therapy of Parkinson's disease].
    Gehlen W
    Z Allgemeinmed; 1975 Nov; 51(33):1543-4. PubMed ID: 1210361
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug for "off" episodes of Parkinson's--effective but limited.
    Mayo Clin Health Lett; 2005 Jul; 23(7):4. PubMed ID: 16189845
    [No Abstract]   [Full Text] [Related]  

  • 14. New drug helps Parkinson's "off" periods.
    Health News; 2004 Jul; 10(7):2. PubMed ID: 15239150
    [No Abstract]   [Full Text] [Related]  

  • 15. "On-off"-induced lethal hyperthermia.
    Pfeiffer RF; Sucha EL
    Mov Disord; 1989; 4(4):338-41. PubMed ID: 2811893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's focus. Parkinson's is debilitating but new treatments are on the horizon.
    Hermanns M
    RN; 2008 Oct; 71(10):24-8; quiz 29. PubMed ID: 18942321
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for Parkinson's Disease.
    Treat Guidel Med Lett; 2004 Jun; 2(22):41-6. PubMed ID: 15529113
    [No Abstract]   [Full Text] [Related]  

  • 18. Levodopa for Parkinson's disease.
    Gérard JM; Elosegi JA
    N Engl J Med; 2009 Feb; 360(9):936; author reply 936. PubMed ID: 19256032
    [No Abstract]   [Full Text] [Related]  

  • 19. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    Wenzelburger R
    Clin Neurophysiol; 2005 Sep; 116(9):1997-8. PubMed ID: 16055380
    [No Abstract]   [Full Text] [Related]  

  • 20. ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs.
    Vautier S; Fernandez C
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1349-58. PubMed ID: 19663741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.